TECTONIC THERAPEUTIC, INC. Temporary Equity, Liquidation Preference
TECTONIC THERAPEUTIC, INC. (TECX) had Temporary Equity, Liquidation Preference of $87.50 million as of 2018-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Balance Sheet › Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2019-05-13
- 2018-03-31: Temporary Equity, Liquidation Preference $87.50M.
- 2017-12-31: Temporary Equity, Liquidation Preference $26.50M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2018-03-31 | $87.50M 10-Q · filed 2019-05-13 |
| 2017-12-31 | $26.50M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |